Roy R. Teller

Array ( [id] => 4899775 [patent_doc_number] => 20080119389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Compositions Comprising Epigallocatechin Gallate and Protein Hydrolysate' [patent_app_type] => utility [patent_app_number] => 11/883051 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9226 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119389.pdf [firstpage_image] =>[orig_patent_app_number] => 11883051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677359 [patent_doc_number] => 20060182714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides' [patent_app_type] => utility [patent_app_number] => 11/344767 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30635 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182714.pdf [firstpage_image] =>[orig_patent_app_number] => 11344767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843469 [patent_doc_number] => 20060121591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Mutant proteinase-inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/341567 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11635 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121591.pdf [firstpage_image] =>[orig_patent_app_number] => 11341567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678312 [patent_doc_number] => 20060183668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Novel insulin derivatives' [patent_app_type] => utility [patent_app_number] => 11/343005 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18516 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183668.pdf [firstpage_image] =>[orig_patent_app_number] => 11343005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520908 [patent_doc_number] => 20090028889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2)' [patent_app_type] => utility [patent_app_number] => 11/815092 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26207 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028889.pdf [firstpage_image] =>[orig_patent_app_number] => 11815092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677361 [patent_doc_number] => 20060182716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/330917 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 118022 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182716.pdf [firstpage_image] =>[orig_patent_app_number] => 11330917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678311 [patent_doc_number] => 20060183667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Stabilised insulin compositions' [patent_app_type] => utility [patent_app_number] => 11/328606 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5686 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183667.pdf [firstpage_image] =>[orig_patent_app_number] => 11328606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 195939 [patent_doc_number] => 07635682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Tumor activated prodrugs' [patent_app_type] => utility [patent_app_number] => 11/328491 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9052 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635682.pdf [firstpage_image] =>[orig_patent_app_number] => 11328491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704868 [patent_doc_number] => 20060193916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Formulations of peptides for periodontal and dental treatments' [patent_app_type] => utility [patent_app_number] => 11/327153 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15408 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193916.pdf [firstpage_image] =>[orig_patent_app_number] => 11327153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667599 [patent_doc_number] => 20060172949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Compositions for preventing and treating digestive organs diseases' [patent_app_type] => utility [patent_app_number] => 11/322254 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7076 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172949.pdf [firstpage_image] =>[orig_patent_app_number] => 11322254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667813 [patent_doc_number] => 20060173163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Synthesis using peptide intermediate fragments' [patent_app_type] => utility [patent_app_number] => 11/322394 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21616 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173163.pdf [firstpage_image] =>[orig_patent_app_number] => 11322394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239624 [patent_doc_number] => 07592341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Peptide-enhanced corneal drug delivery' [patent_app_type] => utility [patent_app_number] => 11/304929 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 8918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592341.pdf [firstpage_image] =>[orig_patent_app_number] => 11304929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363673 [patent_doc_number] => 08252737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Antimicrobial peptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/721915 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31233 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11721915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441011 [patent_doc_number] => 20090092650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Sustained Delivery Formulations of Octreotide Compounds' [patent_app_type] => utility [patent_app_number] => 11/793296 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 53314 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092650.pdf [firstpage_image] =>[orig_patent_app_number] => 11793296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866284 [patent_doc_number] => 20060100415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Process for purifying glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 11/301740 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15089 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100415.pdf [firstpage_image] =>[orig_patent_app_number] => 11301740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13767 [patent_doc_number] => 07803751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Compositions and methods for detecting phosphomonoester' [patent_app_type] => utility [patent_app_number] => 11/298907 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17244 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803751.pdf [firstpage_image] =>[orig_patent_app_number] => 11298907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5184099 [patent_doc_number] => 20070055453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis' [patent_app_type] => utility [patent_app_number] => 11/296927 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10839 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20070055453.pdf [firstpage_image] =>[orig_patent_app_number] => 11296927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886359 [patent_doc_number] => 20080260691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Prodrugs of Ribavirin with Improved Hepatic Delivery' [patent_app_type] => utility [patent_app_number] => 11/718311 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9321 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260691.pdf [firstpage_image] =>[orig_patent_app_number] => 11718311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747851 [patent_doc_number] => 20060110782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Compositions and methods for modification of biomolecules' [patent_app_type] => utility [patent_app_number] => 11/264463 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22582 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110782.pdf [firstpage_image] =>[orig_patent_app_number] => 11264463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966989 [patent_doc_number] => 07939629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Method for solid phase peptide synthesis' [patent_app_type] => utility [patent_app_number] => 11/665541 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5841 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939629.pdf [firstpage_image] =>[orig_patent_app_number] => 11665541 [rel_patent_id] =>[rel_patent_doc_number] =>)